Technology transfer / Localization · GCC · Announced 30 Nov 2025
Algorithm → Batterjee Pharma
Lebanon's Algorithm signed a strategic partnership with Batterjee Pharma to manufacture its lipid and blood-pressure products in Saudi Arabia, with full technology transfer targeted by mid-2026.
Parties: Algorithm (Lebanon) → Batterjee Pharma (Saudi Arabia)
- Deal type
- Technology transfer / Localization
- Value
- Undisclosed
- Territory
- Saudi Arabia
- Therapeutic area
- Cardiovascular
- Assets
- Lipid-lowering products; Antihypertensive products
- Announced
- 30 Nov 2025
Our analysis
Why this matters
On 30 November 2025, Batterjee Pharma and Lebanon's Algorithm announced a strategic partnership to localise manufacture and supply of Algorithm products holding European and Japanese licences in Saudi Arabia. The deal covers full transfer of manufacturing technology, targeted for completion by mid-2026. Products are treatments for hyperlipidaemia, dyslipidaemia and hypertension; the molecules were not named. No financial terms were disclosed. The article describes Algorithm as the first Lebanese company to localise some of its registered products in the Saudi market.
For BD directors at mid-sized Levant and North African companies: Saudi localisation is not only for multinationals. A local contract partner can protect market access as procurement rules favour local products.
The full analysis is free to read with a work email on this page.
Source: Souq Al Dawaa Saudi